These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 6767559)

  • 1. [Interactions between rheumatoid factors and antinuclear autoantibodies: their occurrence in a concealed state in rheumatoid disease (arthritis); effect of D-penicillamine].
    Mach PS; Delbarre F; Piatier D
    C R Seances Acad Sci D; 1980 Feb; 290(8):575-8. PubMed ID: 6767559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between IgM antiglobulins and IgG antinuclear antibodies. Some aspects of D-penicillamine activities.
    Mach PS; Piatier D; Le Go A; Delbarre F
    Clin Exp Immunol; 1979 May; 36(2):311-6. PubMed ID: 383333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidden anti-nuclear antibodies in rheumatic diseases.
    Mach PS; Piatier D; Le Go A; Delbarre F
    Clin Exp Immunol; 1980 Feb; 39(2):538-43. PubMed ID: 6993073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to demonstrate any interaction between polyclonal rheumatoid factors and IgG antinuclear antibodies or other IgG autoantibodies.
    Scott-Morgan L; Lloyd RS
    Clin Exp Immunol; 1980 Aug; 41(2):297-302. PubMed ID: 6160005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
    Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
    Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug effects on autoantibodies and immune complexes.
    Holborow EJ
    Agents Actions Suppl; 1980; 7():58-61. PubMed ID: 6972690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
    Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
    Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
    [No Abstract]   [Full Text] [Related]  

  • 8. [Optic immunofluorescence demonstration of monoclonal and polyclonal antinuclear antibodies (ANA) in rheumatoid arthritis (RA) and lupus erythematosus disseminatus (LED)].
    Dreher R; Helmke K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():808-13. PubMed ID: 417508
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of Clq binding activity by IgM rheumatoid factor.
    Zilberfarb JL; Andrews BS; Young AC; Davis JS
    J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
    Weinstein A; Rothfield NF
    J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis.
    Quismorio FP; Beardmore T; Kaufman RL; Mongan ES
    Clin Exp Immunol; 1983 May; 52(2):333-40. PubMed ID: 6602676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of D-penicillamine on circulating protein complexes in rheumatoid arthritis and primary biliary cirrhosis.
    Wollheim FA
    J Rheumatol Suppl; 1981; 7():74-9. PubMed ID: 7014877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphologic and immunomorphologic studies in rheumatoid arthritis and systemic lupus erythematosus].
    Wagner T
    Patol Pol; 1984; 35(1):45-64. PubMed ID: 6333663
    [No Abstract]   [Full Text] [Related]  

  • 14. The significance of IgM antinuclear antinuclear antibody in rheumatoid arthritis and other connective tissue diseases.
    Chellingworth MC; Salmon M; Scott DL; Bacon PA
    Rheumatol Int; 1984; 4(1):23-5. PubMed ID: 6609412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunoglobulins and autoantibodies. (Characterization studies of some autoantibodies and clinical observations)].
    Bonomo L
    G Mal Infett Parassit; 1966 Dec; 18(12):Suppl:993-1004. PubMed ID: 4173183
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
    Wager O
    Ann Clin Res; 1975 Jun; 7(3):168-82. PubMed ID: 1103712
    [No Abstract]   [Full Text] [Related]  

  • 18. Naturally occurring low molecular weight IgM in patients with rheumatoid arthritis, systemic lupus erythematosus and macroglobulinemia. I. Purification and immunologic studies.
    Harisdangkul V; McDougal JS; Knapp M; Christian CL
    J Immunol; 1975 Jul; 115(1):216-22. PubMed ID: 807624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
    Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
    Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases.
    Miyawaki S; Ritchie RF
    J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.